{
  "id": 1763,
  "text": "0 0 6 \\dot { }$ ).Based on these results, Monk et al.1644,1659 undertook a RCT comparing four cisplatincontaining doublet combinations in FIGO stage IVB, recurrent, or persistent cervical cancer (paclitaxel/cisplatin, vinorelbine/cisplatin, gemcitabine/cisplatin, topotecan/cisplatin).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 0 0 6 \\dot { }$ ).Based on these results, Monk et al.1644,1659 undertook a RCT comparing four cisplatincontaining doublet combinations in FIGO stage IVB, recurrent, or persistent cervical cancer (paclitaxel/cisplatin, vinorelbine/cisplatin, gemcitabine/cisplatin, topotecan/cisplatin).\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果，Monk等人进行了一项随机对照试验，比较了FIGO第IVB期、复发或持续子宫颈癌患者中包含顺铂的四种联合疗法（紫杉醇/顺铂、长春新碱/顺铂、吉西他滨/顺铂、托泊替康/顺铂）的疗效。",
  "query": "在这项研究中，哪种治疗方案在FIGO第IVB期、复发或持续子宫颈癌患者中显示出更好的效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在这项研究中，哪种治疗方案在FIGO第IVB期、复发或持续子宫颈癌患者中显示出更好的效果？\n\n<reference text>: 0 0 6 \\dot { }$ ).Based on these results, Monk et al.1644,1659 undertook a RCT comparing four cisplatincontaining doublet combinations in FIGO stage IVB, recurrent, or persistent cervical cancer (paclitaxel/cisplatin, vinorelbine/cisplatin, gemcitabine/cisplatin, topotecan/cisplatin).\n\n<reply>: ",
  "response": "根据研究结果，Monk等人进行了一项随机对照试验，比较了FIGO第IVB期、复发或持续子宫颈癌患者中包含顺铂的四种联合疗法（紫杉醇/顺铂、长春新碱/顺铂、吉西他滨/顺铂、托泊替康/顺铂）的疗效。"
}